Martin Boyle

Manager, SEC Compliance and Financial Reporting at Inozyme Pharma - Boston, MA, US

Martin Boyle's Colleagues at Inozyme Pharma
Gabrielle Jones

Senior Clinical Data Manager

Contact Gabrielle Jones

Denis Schrier

Vice President, Toxicology

Contact Denis Schrier

Gloria Williams

Snr. Quality Assurance Associate

Contact Gloria Williams

Henric Bjarke

Chief Operating Officer

Contact Henric Bjarke

Catherine Nester

Vice President Physician and Patient Strategies

Contact Catherine Nester

View All Martin Boyle's Colleagues
Martin Boyle's Contact Details
HQ
857-330-4340
Location
Boston, Massachusetts
Company
Inozyme Pharma
Martin Boyle's Company Details
Inozyme Pharma logo, Inozyme Pharma contact details

Inozyme Pharma

Boston, MA, US • 100 - 249 Employees
BioTech/Drugs

We are a biopharmaceutical company specializing in the development of novel therapeutics to treat rare metabolic diseases. Our lead product candidate is INZ-701, an enzyme replacement therapy (ERT) in the early stages of clinical development for the potential treatment of patients with a variety of calcification disorders linked primarily to mutations in the ENPP1 and ABCC6 genes, or ENPP1 Deficiency and ABCC6 Deficiency respectively. We have demonstrated proof of concept with INZ-701 in both GACI and ARHR2 two phenotypes of ENPP1 Deficiency.

N/A
Details about Inozyme Pharma
Frequently Asked Questions about Martin Boyle
Martin Boyle currently works for Inozyme Pharma.
Martin Boyle's role at Inozyme Pharma is Manager, SEC Compliance and Financial Reporting.
Martin Boyle's email address is ***@inozyme.com. To view Martin Boyle's full email address, please signup to ConnectPlex.
Martin Boyle works in the BioTech/Drugs industry.
Martin Boyle's colleagues at Inozyme Pharma are April Sheedy, Gabrielle Jones, Denis Schrier, Gloria Williams, Henric Bjarke, Catherine Nester, Jean-Christophe Francois and others.
Martin Boyle's phone number is 857-330-4340
See more information about Martin Boyle